Clinical Trial Update: Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. [Phase 2]

View source ↗

Summary

Phase 2 early study evaluating the safety and tolerability of tamoxifen in cystic fibrosis patients unable to use CFTR modulators; status indicates the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Cystic Fibrosis - Complete | Phase 2 | Status: NOT_YET_RECRUITING